← Open Payments lookup

SAURABH JAUHARI: Open Payments

NPI 1558507707 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$670 in 31 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $670

Food & beverage: $670
CompanyPaymentsAmount
ABBVIE INC.10$199
Vanda Pharmaceuticals Inc.6$153
Teva Pharmaceuticals USA, Inc.3$86
Otsuka America Pharmaceutical, Inc.2$38
Lundbeck LLC2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
E.R. Squibb & Sons, L.L.C.2$30
Almatica Pharma LLC1$28
Janssen Pharmaceuticals, Inc1$26
Neurocrine BioSciences, Inc.1$19

Products named: VRAYLAR, FANAPT, AUSTEDO XR, ABILIFY ASIMTUFII, CAPLYTA, COBENFY, LOREEV XR, SPRAVATO.

Industry payments across AZ — which companies pay providers there.